This CAR T-cell therapy has revolutionized the management of high-risk and relapsed or refractory disease.
Jordan D. Scott, PharmD
Advertisement
Articles by Jordan D. Scott, PharmD
An interdisciplinary discussion addresses the disparity in availability and use of these therapies across the continuum of care.
Advertisement
Latest Updated Articles
Operationalizing Bispecific Antibodies Across Academic and Community Oncology Centers in Hematologic MalignanciesPublished: June 25th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Understanding RSV in Older Adults: Risks, Symptoms, and Barriers to Vaccination
2
Patients Critically Ill With COVID-19 Have Heightened Risk of Pulmonary Fibrosis
3
Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals
4
Pharmacists Can Provide Trusted Medical Advice in an Era of Fractured Health Care
5
